Cefpirome

Cefpirome

Gene therapy
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01DE02 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name 1-{[(6R,7R)-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-5H,6H,7H-cyclopenta[b]pyridin-1-ium
CAS Number	84957-29-9 Y
PubChem Template:Abbreviation	6917674
ChemSpider	23089536 N
UNII	S72Q2F09HY
KEGG	D07649 Y
ChEMBL	ChEMBL2106076 N
Chemical and physical data
Formula	C22H22N6O5S2
Molar mass	514.58 g/mol
3D model (JSmol)	Interactive image
SMILES CON=C(c1csc(n1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[n+]4cccc5c4CCC5)C(=O)[O-]
InChI InChI=1S/C22H22N6O5S2/c1-33-26-15(13-10-35-22(23)24-13)18(29)25-16-19(30)28-17(21(31)32)12(9-34-20(16)28)8-27-7-3-5-11-4-2-6-14(11)27/h3,5,7,10,16,20H,2,4,6,8-9H2,1H3,(H3-,23,24,25,29,31,32)/b26-15-/t16-,20+/m1/s1 N Key:DKOQGJHPHLTOJR-XECLGWKCSA-N N
Template:XmarkY (what is this?)  (verify)

WikiDoc Resources for Cefpirome
Articles
Most recent articles on Cefpirome Most cited articles on Cefpirome Review articles on Cefpirome Articles on Cefpirome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefpirome Images of Cefpirome Photos of Cefpirome Podcasts & MP3s on Cefpirome Videos on Cefpirome
Evidence Based Medicine
Cochrane Collaboration on Cefpirome Bandolier on Cefpirome TRIP on Cefpirome
Clinical Trials
Ongoing Trials on Cefpirome at Clinical Trials.gov Trial results on Cefpirome Clinical Trials on Cefpirome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefpirome NICE Guidance on Cefpirome NHS PRODIGY Guidance FDA on Cefpirome CDC on Cefpirome
Books
Books on Cefpirome
News
Cefpirome in the news Be alerted to news on Cefpirome News trends on Cefpirome
Commentary
Blogs on Cefpirome
Definitions
Definitions of Cefpirome
Patient Resources / Community
Patient resources on Cefpirome Discussion groups on Cefpirome Patient Handouts on Cefpirome Directions to Hospitals Treating Cefpirome Risk calculators and risk factors for Cefpirome
Healthcare Provider Resources
Symptoms of Cefpirome Causes & Risk Factors for Cefpirome Diagnostic studies for Cefpirome Treatment of Cefpirome
Continuing Medical Education (CME)
CME Programs on Cefpirome
International
Cefpirome en Espanol Cefpirome en Francais
Business
Cefpirome in the Marketplace Patents on Cefpirome
Experimental / Informatics
List of terms related to Cefpirome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, and Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria.

Spectrum of bacterial susceptibility and resistance

Bacteroides fragilis, enterococci, Pseudomonas spp. and staphylococci are resistant to cefpirome sulfate, and some Haemophilus spp. and pneumococci have developed resistance to it to varying degrees.